Clinical Trial Detail

NCT ID NCT01449279
Title Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanford University
Indications

melanoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.